Berlin, Germany · Founded 2023 · Privately Held (backing)
Developer of a precision oncology platform designed to advance cancer diagnostics through next-generation biomarker discovery. StratifAI is based in Berlin, Germany and was founded in 2023. It has raised $16.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$16.3M
Last round
—
Cap table — not yet on record
StratifAI's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of StratifAI with a free account
·The complete investor list: 14 names
·Watch StratifAI: the Monday email on marks, rounds and moves
